₹679.35
▲ +2.37 +0.35%
As of 28 Jul 2026 · delayed
NSE Listed · Healthcare
Healthcare Global Enterprises Ltd. (HCG)
Volume: 94,231Avg Vol 1W: 1,06,898Avg Vol 1M: 2,59,80252W Range:₹513.3₹799.71
Key Ratios
Checked just nowMarket Cap₹10,143 Cr
Current Price₹679.35
Previous Close₹676.98
High / Low (52w)₹799.71 / ₹513.3
Volume94,231
Avg Vol (1W)1,06,898
Avg Vol (1M)2,59,802
Stock P/E4,529
Book Value₹89.21
Dividend Yield0%
ROE2.9%
ROA0.58%
Revenue (TTM)—
Revenue Growth16.26%
Profit Margin0.54%
Total Debt₹605 Cr
Shares Outstanding15 Cr
Face Value₹10
EPS (TTM)₹0.15
P/B7.61
Debt / Equity1.3
50 DMA₹643.15
200 DMA₹637.52
Day change+0.35%
Price Chart
₹679.35▲ 16.46% · 1Y
2025-07-292026-07-28
20-day avg volume: 2.6L shares
Pros
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 4529.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹526 Cr | ₹554 Cr | ₹559 Cr | ₹585 Cr | ₹613 Cr | ₹647 Cr | ₹633 Cr | ₹652 Cr |
| EBITDA | ₹53 Cr | ₹64 Cr | ₹37 Cr | ₹58 Cr | ₹57 Cr | ₹63 Cr | ₹51 Cr | ₹75 Cr |
| Net Profit | ₹12 Cr | ₹18 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹16 Cr | ₹-9 Cr | ₹2 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹329 Cr | ₹313 Cr | ₹324 Cr | ₹2,258 Cr | ₹327 Cr | ₹346 Cr | ₹342 Cr | ₹350 Cr |
| EBITDA | ₹43 Cr | ₹20 Cr | ₹39 Cr | ₹211 Cr | ₹30 Cr | ₹36 Cr | ₹27 Cr | ₹59 Cr |
| Net Profit | ₹18 Cr | ₹-37 Cr | ₹10 Cr | ₹44 Cr | ₹3 Cr | ₹11 Cr | ₹-1 Cr | ₹2 Cr |
| EPS | — | — | — | 3.14 | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹1,444 Cr | ₹1,654 Cr | ₹2,253 Cr | ₹2,036 Cr | ₹2,220 Cr | ₹2,316 Cr | ₹2,707 Cr | ₹3,543 Cr |
| Total Liabilities | ₹865 Cr | ₹1,131 Cr | ₹1,833 Cr | ₹1,322 Cr | ₹1,336 Cr | ₹1,447 Cr | ₹1,842 Cr | ₹2,553 Cr |
| Equity | ₹579 Cr | ₹522 Cr | ₹420 Cr | ₹714 Cr | ₹884 Cr | ₹869 Cr | ₹865 Cr | ₹990 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹102 Cr | ₹136 Cr | ₹157 Cr | ₹83 Cr | ₹244 Cr | ₹274 Cr | ₹332 Cr | ₹349 Cr |
| Investing | ₹-282 Cr | ₹-238 Cr | ₹-101 Cr | ₹-171 Cr | ₹125 Cr | ₹-133 Cr | ₹-226 Cr | ₹-488 Cr |
| Financing | ₹161 Cr | ₹84 Cr | ₹-58 Cr | ₹112 Cr | ₹-155 Cr | ₹-140 Cr | ₹-64 Cr | ₹-42 Cr |
| Free Cash Flow | ₹102 Cr | ₹136 Cr | ₹157 Cr | ₹83 Cr | ₹244 Cr | ₹274 Cr | ₹332 Cr | ₹349 Cr |
Shareholding
Promoter 64.21% Institutions 21.94% Public 13.85%
Efficiency & Working Capital
ROCE7.1%
Interest Coverage1.4
Dividend Payout—
Debtor Days66 d
Inventory Days9 d
Payable Days55 d
Cash Conversion Cycle20 d
Working Capital Days75 d
Shareholding Details
As of 2026-06-30
Promoter64.2%
FII2.7%
DII19.2%
Institutions21.9%
Public13.9%
Promoter Pledge5.2%
No. of Shareholders48,905
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.3% | 71.3% | 71.3% | 71.3% | 71.2% | 71.2% | 71.2% | 62.5% | 63.8% | 63.8% | 64.2% | 64.2% |
| FIIs | 6.3% | 6.4% | 6.7% | 4% | 4.3% | 2.8% | 2.4% | 2.2% | 3.6% | 3.2% | 2.8% | 2.7% |
| DIIs | 7.9% | 6.7% | 8.5% | 10.9% | 11.6% | 12.9% | 12.5% | 13.2% | 18.4% | 18.3% | 18.9% | 19.2% |
| Public | 14.5% | 15.7% | 13.5% | 13.9% | 12.8% | 13.1% | 13.9% | 22.2% | 14.3% | 14.7% | 14.1% | 13.9% |
| Promoter Pledge | 3.1% | 0% | 3.1% | 3.1% | 3.1% | 3.1% | 5% | 88% | 85.2% | 85.2% | 5.2% | 5.2% |
| No. of Shareholders | 27,327 | 27,289 | 27,195 | 26,529 | 29,670 | 32,820 | 45,394 | 47,028 | 46,970 | 45,366 | 47,649 | 48,905 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Hector Asia Holdings Ii Pte. Ltd. | Shareholding of Promoter and Promoter Group | 54.3% | 8.10 Cr |
| B S Ajaikumar | Shareholding of Promoter and Promoter Group | 9.3% | 1.39 Cr |
| Nippon Life India Trustee Ltd-a/c Nippon India Els | Public Shareholding | 5.9% | 87,80,023 |
| Axis Mutual Fund Trustee Limited A/c Axis Mutual Fund | Public Shareholding | 3.6% | 53,39,759 |
| Tata Mutual Fund - Tata Elss Fund | Public Shareholding | 3% | 45,18,589 |
| Motilal Oswal S&p Bse Healthcare Etf | Public Shareholding | 2.5% | 36,72,042 |
| Clarus Capital I | Public Shareholding | 1.4% | 20,49,664 |
| Asmitha Ajaikumar | Shareholding of Promoter and Promoter Group | 0.2% | 3,46,509 |
| Aagnika Ajaikumar | Shareholding of Promoter and Promoter Group | 0.2% | 3,46,508 |
| Catalyst Trusteeship Limited | Shareholding of Promoter and Promoter Group | 0.2% | 2,64,752 |
| Bhagya A Ajaikumar | Shareholding of Promoter and Promoter Group | 0% | 1,900 |
| Anjali Ajaikumar Rossi | Shareholding of Promoter and Promoter Group | 0% | 1,058 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| B S Ajaikumar | 49,59,539 | 35.7% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| BASAVALINGA AJAIKUMAR SADASHIVAIAH | Chairman (Non-Executive) | 2025 |
| Anjali Ajaikumar Rossi | Non-Exec & Non-Independent Dir | 2025 |
| Geet Mathur | Independent Non Exe. Director | 2025 |
| RAJAGOPALAN RAGHAVAN | Independent Non Exe. Director | 2025 |
| Pradip M. Kanakia | Independent Non Exe. Director | 2025 |
| Rajiv Maliwal | Independent Non Exe. Director | 2025 |
| MANISH MATTOO | Executive Director & CEO | 2025 |
| AKSHAY TANNA | Non-Exec & Non-Independent Dir | 2025 |
| SIMRUN MEHTA | Non-Exec & Non-Independent Dir | 2025 |
| Bijou Kurien | Independent Non Exe. Director | 2025 |
| SUNU MANUEL | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Medical and Healthcare Services | ₹0 Cr | — |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹1,277 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 200 | 139 | 139 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-06 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 637 | 0 | 0 | 21 | 8 | 669 |
| 2025 | 11 | 0 | 0 | 0 | 2 | 13 |
| 2025 | 347 | 0 | 0 | 21 | 4 | 374 |
Insider / Designated-Person Trades
92 recent disclosure(s)
NIKUNJ RAMNIKLAL BHAMBHADisposal · 1,530
Yuva Kishore TerliDisposal · 3,000
Sunu ManuelDisposal · 4,201
Punitha Rani SinghDisposal · 2,002
BHAGYA A AJAIKUMARAcquisition · 105
DR B S AJAIKUMARAcquisition · 7,70,982
Substantial Acquisitions (SAST)
2 disclosure(s)
Market04/05/2026 · 5,19,430
Market29/10/2025 · 1,54,556
Company Information
Incorporated1998
ChairmanBASAVALINGA AJAIKUMAR SADASHIVAIAH
AuditorB S R & Co LLP
Investor Email[email protected]; [email protected]
📍 HCG Tower No 8 Kalinga Rao Rd, Sampangi Rama Nagar, Bangalore, Karnataka, 560027
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Sri Havisha Hospitality & Infrastructure Ltd.Hawkins Cookers Ltd.H B Estate Developers LimitedHBL Engineering Ltd.HB StockholdingsHindustan Construction Company Ltd.HCL Infosystems Ltd.HCL Technologies Ltd.HDB Financial Services LimitedHDFC Asset Management Company Ltd.HDFC Bank Ltd.HDFC Life Insurance Company Ltd.All “H” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search